Fairvalue-Calculator Fairvalue-Calculator
EN DE

Original BioMedicals Co (6483) Fair Value & Analysis

Healthcare · TW · Market cap 839M TWD

Price11.80 TWD
Fair Value2.07 TWD
Upside-82.5%
Quality91/100
Evidence: Low Range 1.37 TWD – 2.59 TWD

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Original BioMedicals Co (6483) currently trades at 11.80 TWD, while our model-based Fair Value estimate is 2.07 TWD — implying the stock looks roughly 82.5% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Original BioMedicals Co., Ltd., engages in the development of new drugs without new ingredients in Taiwan. The company develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic; and Iron Dextran, an injection for treatment of iron deficiency. It also provides NE (Vit. C+E); and NE Butorphanol. The company was founded in 2011 and is based in Tainan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Original BioMedicals Co (6483) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 2.07 TWD versus a price of 11.80 TWD — about −82% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6483?
Our 21-model fair value for Original BioMedicals Co is 2.07 TWD (as of Jun 26, 2026), built from audited fundamentals. The current price is 11.80 TWD.
What is the quality score of 6483?
Original BioMedicals Co has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.